发明名称 ORAL PHARMACEUTICAL COMPOSITION
摘要 <p>The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions. An oral pharmaceutical composition comprising ±,±,±-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt.</p>
申请公布号 SG11201403875V(A) 申请公布日期 2014.10.30
申请号 SG11201403875V 申请日期 2013.02.14
申请人 TAIHO PHARMACEUTICAL CO., LTD. 发明人 OHNISHI, YOSHITO;OGATA, TETSUO
分类号 A61K31/7068;A61K9/14;A61K9/20;A61K9/30;A61K31/513;A61K47/10;A61K47/12;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61K47/44;A61P35/00;A61P43/00 主分类号 A61K31/7068
代理机构 代理人
主权项
地址